ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NAS To Honor Outstanding Scientists

February 28, 1997

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

In Brief: Streamlining Of Contract Award Process Still Top Priority At NCI; Training Grants No Closer

January 10, 1975

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014